Ticker Details
DexCom, Inc. DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.
IPO Date:	April 14, 2005
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$28.6B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.87 | 2.19%
Avg Daily Range (30 D):	$1.30 | 1.79%
Avg Daily Range (90 D):	$1.24 | 1.86%

Institutional Daily Volume
Avg Daily Volume:	1.13M
Avg Daily Volume (30 D):	3.6M
Avg Daily Volume (90 D):	3.73M

Trade Size
Avg Trade Size (Sh.):	71
Avg Trade Size (Sh.) (30 D):	59
Avg Trade Size (Sh.) (90 D):	60

Institutional Trades
Total Institutional Trades:	21,408
Avg Institutional Trade:	$7.3M
Avg Institutional Trade (30 D):	$9.92M
Avg Institutional Trade (90 D):	$8.98M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	5

Market Closing Trades
Avg Closing Trade:	$25.66M
Avg Closing Trade (30 D):	$84.44M
Avg Closing Trade (90 D):	$70.81M
Avg Closing Volume:	376.86K

News

Jul 14, 2026 @ 4:30 AM Global Blood Glucose Monitoring System Market Size... Source: Custom Market Insights

Jun 18, 2026 @ 3:41 PM 3 Stocks Doing the Heavy Lifting in Healthcareââ‚... Source: Jessica Mitacek

Jun 15, 2026 @ 5:02 PM Dexcom Scores Pediatric Expansion For OTC Stelo Gl... Source: Vandana Singh

Jun 4, 2026 @ 5:53 PM [Latest] Non-Invasive Blood Glucose Monitoring Dev... Source: Zion Market Research

May 15, 2026 @ 5:41 PM Diabetes Tech Player DexCom Lays Out 2030 Growth V... Source: Vandana Singh

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$2.14	$.69	$2.14
Diluted EPS	$2.09	$.67	$2.09
Revenue	$4.66B	$1.26B	$4.66B
Gross Profit	$2.8B	$792.7M	$2.8B
Net Income / Loss	$836.3M	$267.3M	$836.3M
Operating Income / Loss	$911.8M	$323M	$911.8M
Cost of Revenue	$1.86B	$466.9M	$1.86B
Net Cash Flow	$311.8M	$-917.8M	$311.8M
PE Ratio

Splits
Jun 13, 2022	4:1